|
|
429 Lenox Avenue, Suite P-703
Miami Beach, FL 33139 USA
phone:305-432-4684
fax:305-503-8566
|
|
| Symbol |
private |
| Founded |
2008 |
| Employees |
10 |
|
|
| www.heatbio.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Technology to treat cancers, viral and autoimmune diseases |
|
| Management |
| Jeff Wolf, Chairman; Taffy Williams Ph.D., President; Eckhard Podack, M.D.,Ph.D, Chief Scientific Officer; Stanley Kim Ph.D., J.D., General Counsel; |
| |
|
|
| |
|
| Keywords |
| Heat, cancers, viral, autoimmune diseases, immune system, Asthma, proteins |
|
|
|
| Description |
|
Heat Biologics (www.heatbio.com) is a clinical stage immunotherapy company focused on developing novel, off-the-shelf drugs that modulate the immune system to combat a wide range of cancers and viral infections, including HIV, Hepatitis C and influenza. Less invasive than personalized (autologous) immunotherapies, which require treatment of the patient�s own cancer or blood, Heat�s proprietary off-the-shelf (allogeneic) ImPACT therapy exploits the natural ability of diseased cells to activate the immune system and amplifies the body�s natural defenses. The company is currently in Phase I/II clinical trials with its first product, a drug to treat Non-�-Small Cell Lung Cancer (NSCLC), and has a robust pipeline of products in various stages of preclinical testing. |
|
| Technology / Differentiation |
| Immune modulators including HeatShock technology and Inhibicor; regulation of antibodies; T-cell modulation; heat shock proteins; tumor necrosis factor. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members